Validating response and toxicity predictions of the "virtual patient" in neoadjuvant and adjuvant breast cancer chemotherapy

被引：0
|
作者：
Ariad, S.
Chan, S.
Agur, Z.
机构：
[1] Soroka Med Ctr, IL-84101 Beer Sheva, Israel
[2] City Hosp Nottingham, Nottingham, England
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(07)71793-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O103
引用
下载
收藏
页码：31 / 32
页数：2
相关论文
共 50 条
  • [21] PREDICTION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN BREAST CANCER
    Myllys, Maiju
    EXCLI JOURNAL, 2021, 20 : 625 - 627
  • [22] DELAYED CARDIAC TOXICITY IN BREAST CANCER PATIENTS TREATED WITH ADJUVANT OR NEOADJUVANT CHEMOTHERAPY (INCLUDING ANTHRACYCLINES) AND TRASTUZUMAB
    Mailliez, A.
    Kotecki, N.
    Kouakam, C.
    Fournier, C.
    Bonneterre, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 113 - 113
  • [23] Comparison of Radiological Burden in Neoadjuvant Chemotherapy and Adjuvant Chemotherapy in Breast Cancer Patients
    Abidin, A. Z.
    Zaheer, M. A.
    Brady, C.
    Duddy, L.
    Corrigan, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S324 - S324
  • [24] Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique
    Takada, M.
    Sugimoto, M.
    Ohno, S.
    Kuroi, K.
    Sato, N.
    Bando, H.
    Masuda, N.
    Iwata, H.
    Kondo, M.
    Sasano, H.
    Chow, L. W. C.
    Inamoto, T.
    Naito, Y.
    Tomita, M.
    Toi, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 661 - 670
  • [25] Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique
    M. Takada
    M. Sugimoto
    S. Ohno
    K. Kuroi
    N. Sato
    H. Bando
    N. Masuda
    H. Iwata
    M. Kondo
    H. Sasano
    L. W. C. Chow
    T. Inamoto
    Y. Naito
    M. Tomita
    M. Toi
    Breast Cancer Research and Treatment, 2012, 134 : 661 - 670
  • [26] Prospective and Comparative Evaluation of the Toxicity of Adjuvant Concurrent Chemo-radiotherapy after Neoadjuvant Chemotherapy for Breast Cancer
    Marchand, V.
    Angelergues, A.
    Gobaux, V.
    Hajage, D.
    Kirova, Y.
    Campana, F.
    Reyal, F.
    Pierga, J.
    Fourquet, A.
    Bollet, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S262 - S262
  • [27] The impact of EGFR gene polymorphisms on the response and toxicity derived from neoadjuvant chemotherapy for breast cancer
    Wang, Yan
    Wu, Ziping
    Zhou, Liheng
    Lu, Jinglu
    Wang, Yaohui
    Lin, Yanping
    Xu, Shuguang
    Ye, Yumei
    Peng, Jing
    Zhang, Jie
    Yin, Wenjin
    Lu, Jinsong
    GLAND SURGERY, 2020, 9 (04) : 925 - +
  • [28] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [29] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [30] ADJUVANT AND NEOADJUVANT TREATMENT OF BREAST-CANCER WITH CHEMOTHERAPY AND OR ENDOCRINE THERAPY
    BONADONNA, G
    VALAGUSSA, P
    BRAMBILLA, C
    MOLITERNI, A
    ZAMBETTI, M
    FERRARI, L
    SEMINARS IN ONCOLOGY, 1991, 18 (06) : 515 - 524
12345